Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05678556 · ClinicalTrials.gov registry record · NA

Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM

A NA study of HIV and Gonorrhea, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
5,000
Enrollment target
1
Study location

NCT05678556: Recruiting NA study of HIV and Gonorrhea, sponsored by Northwestern University.

NCT05678556 is a NA study of HIV and Gonorrhea that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 5,000 participants, above the 423-participant average among 303 other HIV trials with a reported enrollment target (1082% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05678556, a NA study of HIV and Gonorrhea, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
5,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, including both cisgender and transgender men. It is also designed for transgender and non-binary people who partner with cisgender men, including both transfeminine and transmasculine people. The investigators aim to test the effectiveness of this updated program among couples and single people. Participants will complete online surveys and get tested for Chlamydia and Gonorrhea. Participants will be tested for urethral and rectal Chlamydia and Gonorrhea. Participants will also complete at-home point-of-care HIV testing, with confirmatory testing for preliminary positive results. They will also participate in our program on relationship education and HIV prevention. Study staff will follow up with participants for up to 2 years. All participants will be randomized into one of two different conditions: the all2GETHER program or no program. "Randomized" means that it is completely up to chance which condition participants will be put into. Participants have a 50% chance of being assigned to either condition, similar to a coin toss. Participants should expect that they will be in this research study for 2 years. Participation in this study will be done remotely - participants will never need to come into a research lab.

Primary Outcome

Incidence of HIV confirmed via lab processed but self-administered collection

Interventions

  • BEHAVIORAL all2GETHER

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2022-12-15
Est. Completion 2026-03-31
Phase NA
Northwestern University

1,209 total trials

What NCT05678556 shows while recruiting

NCT05678556 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 423-participant average among 303 other HIV trials with a reported enrollment target (1082% higher).

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which all2GETHER is the first listed.

NCT05678556 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05678556 about?

NCT05678556 is a clinical study titled "Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM". The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, includin...

What is the current status of trial NCT05678556?

This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2022-12-15. Estimated completion is 2026-03-31.

What conditions does trial NCT05678556 study?

This clinical trial studies the following conditions: HIV, Gonorrhea, Chlamydia.

What interventions are being tested in trial NCT05678556?

The interventions under investigation include: all2GETHER (BEHAVIORAL).

Who is sponsoring clinical trial NCT05678556?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05678556 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05678556's enrollment target sits among peer trials

5,000 4th of 303 higher than 300 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05678556, the US trial registry maintained by the National Library of Medicine. NCT05678556 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.